The Federal Office for Safety in Health Care (BASG) has been informed by the Italian authorities that, in addition to the provinces already announced, ID WNV NAT testing for blood and blood component donations has been introduced in Foggia, Sassari and Vicenza, Italy.

The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that the ID WNV NAT test for donations of blood and blood components has been introduced in the Département Var in France.

Recall due to leakage

There is a potential health risk, as the safety and efficacy of the counterfeit products are not guaranteed. The contents of the counterfeit products are unknown.

The Federal Office for Safety in Health Care (BASG) has been informed by the French authorities that, in addition to the regions already announced, confirmed autochthonous cases of dengue fever have been recorded in the Ain department in France.

Recall due to impurities

Recall due to impurities

The Federal Office for Safety in Health Care has been informed by the Greek authority that in Greece, in addition to the regions already announced, confirmed human WNV infections have been recorded in East-Attica and Larisa.

The Federal Office for Safety in Health Care (BASG) has been informed about the counterfeit product "NovoFine Plus 32G 4mm" with the batch number NE61324-2 from the manufacturer Novo Nordisk A/S.

The Federal Office for Safety in Health Care (BASG) has been informed that the following products have been counterfeited: - Unbreakable by TCS - IFlex by TCS - Karadent by TCS